Effect of Procedural Volume on In-Hospital Outcomes After Percutaneous Coronary Intervention in Patients With Chronic

Tsuyoshi Ito1, Kyohei Yamaji2, Shun Kohsaka3

  • 1Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Insights

Higher institutional volume for percutaneous coronary intervention (PCI) in patients with chronic kidney disease (CKD) is linked to better in-hospital outcomes. Focusing on institutional CKD-PCI volume can improve decision-making for revascularization in these high-risk patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Health Services Research

Background:

  • Chronic kidney disease (CKD) significantly elevates the risk of adverse outcomes in patients with cardiovascular diseases.
  • Percutaneous coronary intervention (PCI) is a common revascularization strategy, but outcomes may vary based on institutional experience, especially in CKD patients.
  • Understanding the relationship between institutional PCI volume and clinical outcomes in CKD patients is crucial for optimizing care.

Purpose of the Study:

  • To investigate the association between the annual institutional volume of percutaneous coronary intervention (PCI) performed in patients with chronic kidney disease (CKD).
  • To evaluate the impact of institutional CKD-PCI volume on in-hospital clinical outcomes, including death and periprocedural complications.
  • To determine if higher institutional volume correlates with improved procedural characteristics and patient outcomes.

Main Methods:

  • Analysis of a Japanese nationwide registry data from 2014-2018, including 1,199,901 PCI procedures.
  • Focus on 220,509 patients with CKD, categorized into quartiles based on mean annual institutional CKD-PCI volume.
  • Primary outcome: composite of in-hospital death and periprocedural complications. Secondary analysis of procedural characteristics like device use, contrast volume, access site, and door-to-balloon time.

Main Results:

  • Higher institutional CKD-PCI volume was associated with significantly lower rates of the primary composite outcome (3.4% in Q1 vs. 2.4% in Q4, p <0.001).
  • Institutions with the highest PCI volume demonstrated improved procedural efficiency, including lower contrast use, higher radial access rates, and shorter door-to-balloon times for STEMI.
  • An inverse relationship was observed: higher institutional CKD-PCI volume correlated with reduced odds of adverse in-hospital events (OR for Q4 vs. Q1: 0.76 [0.84 to 0.97]).

Conclusions:

  • Institutional volume of percutaneous coronary intervention (PCI) significantly influences procedural characteristics and in-hospital outcomes for patients with chronic kidney disease (CKD).
  • Higher-volume institutions are associated with better clinical results and procedural efficiency in CKD patients undergoing PCI.
  • Institutional CKD-PCI volume should be a key consideration in clinical decision-making for revascularization strategies in patients with CKD.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
244
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
80
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
180
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
132
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
179
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
143